Gravitas Medical

Gravitas Medical has developed the Entarik Platform, an FDA-cleared intelligent system that transforms standard enteral feeding tubes into smart devices. The system uses embedded bio-impedance and temperature sensors to guide accurate placement and monitor tube position in real-time, aiming to eliminate dangerous misplacements into the lungs. The company, which spun out of Theranova, is commercializing its initial product for the ICU and neonatal markets while developing future capabilities to analyze 'gut data' for early complication detection. Its mission is driven by a commitment to prevent tragedies resulting from misplaced feeding tubes.

The Entarik Platform is an enteral nutrition intelligence system that uses feeding tubes embedded with bio-impedance and temperature sensors. It collects real-time 'gut data' to guide accurate placement, continuously monitor tube position, and provide a foundation for future GI data analytics and predictive monitoring of ICU complications.

Competition includes the current standard of care (chest X-ray, auscultation, pH testing) and alternative placement technologies like electromagnetic guidance systems (e.g., Cortrak by Avanos). Gravitas differentiates with real-time guidance, continuous monitoring, and a platform strategy aimed at data-driven complication prediction, rather than just placement.